The human LGALS3 (galectin-3) gene: determination of the gene structure and functional characterization of the promoter

Archives of Biochemistry and Biophysics
M M KadrofskeJ L Wang

Abstract

Galectin-3 is a beta-galactoside-specific lectin that is a pre-mRNA splicing factor. Here we report the genomic organization of the human LGALS3 (galectin-3) gene and functional characterization of the promoter. Southern blot analysis of genomic DNA revealed that galectin-3 is coded by a single gene in the human genome. The gene is composed of six exons and five introns, spanning a total of approximately 17 kilobases (kb). Based on primer extension and ribonuclease protection analyses, there are two transcription initiation sites located 52 and 50 nucleotides (nt) upstream of the exon I-intron 1 border, and defined here as +1a and +1b, respectively. The translation start site is in exon II. The ribonucleoprotein-like N-terminal domain, containing the proline-glycine-alanine-tyrosine (PGAY) repeat motif, is found entirely within exon III. The carbohydrate recognition sequence is found entirely within exon V. Genomic fragments encompassing -836 to +141 nt (relative to +1a) have significant promoter activity when linked to the luciferase reporter gene and transiently transfected into HeLa cells or human diploid fibroblasts. Quiescent fibroblasts have low promoter activity but the activity increases 100-fold following serum additio...Continue Reading

References

Oct 1, 1992·Trends in Biochemical Sciences·R Treisman
May 2, 1991·Biochimica Et Biophysica Acta·L ChiariottiL Mallucci
Jun 4, 1982·Science·C W Schmid, W R Jelinek
Sep 24, 1993·Science·M Montminy

❮ Previous
Next ❯

Citations

Nov 21, 2008·Endocrine·He-Yu ZhangRicardo V Lloyd
Mar 22, 2002·Journal of Internal Medicine·H Vlassara, M R Palace
Sep 21, 2000·Kidney International. Supplement·F PricciG Pugliese
Mar 25, 1999·Glycobiology·S FogelE Hébert
Jun 27, 2013·Toxicological Sciences : an Official Journal of the Society of Toxicology·Junyu LiuJunfeng Zhang
May 14, 2004·Annals of the Rheumatic Diseases·M GuévremontP Reboul
Mar 1, 2007·Arthritis Research & Therapy·Audrée Janelle-MontcalmPascal Reboul
Oct 12, 2012·PloS One·Rudolf A de BoerPim van der Harst
Jan 1, 2014·World Journal of Gastroenterology : WJG·María L BacigalupoMaría F Troncoso
Mar 22, 2006·Proceedings of the National Academy of Sciences of the United States of America·Neil C HendersonTariq Sethi
Aug 12, 2000·Stress : the International Journal on the Biology of Stress·J DumićG Lauc
Nov 30, 2006·International Journal of Andrology·Catherine DeschildreMohamed Benahmed
Mar 26, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Huaiwu LuGuorong Li
Jun 1, 2016·Frontiers in Oncology·Ana Carolina Ferreira CardosoRoger Chammas
Feb 16, 2006·Biochimica Et Biophysica Acta·Jerka DumicMirna Flögel
Aug 18, 2004·Current Opinion in Rheumatology·Pascal ReboulJean-Pierre Pelletier
Jan 5, 2002·Diabetes/metabolism Research and Reviews·H Vlassara
Dec 8, 2015·Clinical Medicine Insights. Oncology·Hafiz Ahmed, Dina M M AlSadek
Oct 30, 2018·Clinical and Experimental Pharmacology & Physiology·Xiao ZhongXiang Song
Jul 15, 2009·Immunological Reviews·Daniel K HsuFu-Tong Liu
Feb 27, 2003·The Journal of Biological Chemistry·Michael StockFlorian Otto
Oct 20, 2019·Cellular and Molecular Life Sciences : CMLS·Charlotte G H M de JongWia Baron
Oct 27, 2011·Journal of Internal Medicine·R A de BoerP van der Harst
Jun 14, 2017·Mediators of Inflammation·Laura Díaz-Alvarez, Enrique Ortega
Feb 19, 2002·Laboratory Investigation; a Journal of Technical Methods and Pathology·Carine DelbrouckRobert Kiss
Dec 19, 2019·Frontiers in Cell and Developmental Biology·Zilong LiYong Xu
Apr 3, 2001·The Journal of Biological Chemistry·R Y YangF T Liu
Mar 1, 2005·Cancer Research·Katharina H RuebelRicardo V Lloyd
Jan 25, 2021·Molecular Biology Reports·Ruth Saez-MaletaJose-Angel Perez-Rivera

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.